GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 35 filers reported holding GLAXOSMITHKLINE PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $325,000 | -42.4% | 7,476 | -42.3% | 0.05% | -43.2% |
| Q1 2022 | $564,000 | -25.1% | 12,955 | -24.1% | 0.09% | -15.4% |
| Q4 2021 | $753,000 | +28.5% | 17,076 | +11.4% | 0.10% | +22.4% |
| Q3 2021 | $586,000 | -12.9% | 15,335 | -9.2% | 0.08% | -16.7% |
| Q2 2021 | $673,000 | +6.8% | 16,897 | -4.3% | 0.10% | 0.0% |
| Q1 2021 | $630,000 | +4.3% | 17,658 | +7.4% | 0.10% | 0.0% |
| Q4 2020 | $604,000 | -5.3% | 16,434 | -3.1% | 0.10% | -17.1% |
| Q3 2020 | $638,000 | +54.9% | 16,961 | +68.6% | 0.12% | +43.0% |
| Q2 2020 | $412,000 | +18.4% | 10,058 | +9.2% | 0.09% | -4.4% |
| Q1 2020 | $348,000 | -19.8% | 9,208 | -0.5% | 0.09% | +11.1% |
| Q4 2019 | $434,000 | +9.9% | 9,257 | 0.0% | 0.08% | +3.8% |
| Q3 2019 | $395,000 | +7.0% | 9,257 | +0.2% | 0.08% | +5.4% |
| Q2 2019 | $369,000 | +23.8% | 9,238 | +29.5% | 0.07% | +19.4% |
| Q1 2019 | $298,000 | +12.9% | 7,134 | +2.9% | 0.06% | -1.6% |
| Q4 2018 | $264,000 | -4.0% | 6,934 | +1.1% | 0.06% | +12.5% |
| Q3 2018 | $275,000 | +13.2% | 6,858 | +13.4% | 0.06% | +5.7% |
| Q2 2018 | $243,000 | -5.4% | 6,050 | -8.2% | 0.05% | -5.4% |
| Q1 2018 | $257,000 | +3.2% | 6,588 | -6.4% | 0.06% | +5.7% |
| Q4 2017 | $249,000 | -22.7% | 7,042 | -11.4% | 0.05% | -24.3% |
| Q3 2017 | $322,000 | -3.9% | 7,948 | +2.1% | 0.07% | -4.1% |
| Q2 2017 | $335,000 | -2.3% | 7,786 | -4.5% | 0.07% | -7.6% |
| Q1 2017 | $343,000 | +5.5% | 8,153 | -3.4% | 0.08% | +1.3% |
| Q4 2016 | $325,000 | -3.6% | 8,444 | +8.0% | 0.08% | -4.9% |
| Q3 2016 | $337,000 | +5.6% | 7,819 | +6.0% | 0.08% | -1.2% |
| Q2 2016 | $319,000 | +30.2% | 7,375 | +21.7% | 0.08% | +25.8% |
| Q1 2016 | $245,000 | +21.9% | 6,058 | +15.8% | 0.07% | +10.0% |
| Q3 2015 | $201,000 | -6.9% | 5,233 | +0.9% | 0.06% | -3.2% |
| Q2 2015 | $216,000 | -11.1% | 5,188 | -1.6% | 0.06% | -11.4% |
| Q1 2015 | $243,000 | +18.5% | 5,274 | +9.5% | 0.07% | +7.7% |
| Q4 2014 | $205,000 | -14.9% | 4,815 | -8.1% | 0.06% | -20.7% |
| Q3 2014 | $241,000 | -25.2% | 5,242 | -13.0% | 0.08% | -21.9% |
| Q2 2014 | $322,000 | +16.2% | 6,022 | +16.1% | 0.10% | +1.0% |
| Q1 2014 | $277,000 | -5.8% | 5,188 | -5.9% | 0.10% | -11.9% |
| Q4 2013 | $294,000 | -5.2% | 5,511 | -10.8% | 0.12% | -15.7% |
| Q3 2013 | $310,000 | +13.1% | 6,175 | +12.8% | 0.14% | +11.1% |
| Q2 2013 | $274,000 | 0.0% | 5,474 | 0.0% | 0.13% | 0.0% |
| Q1 2013 | $274,000 | – | 5,474 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |